bibliographicCitation |
Kuramoto K, Yamada H, Shin T, Sawada Y, Azami H, Yamada T, Nagashima T, Ohnuki K. Development of a potent and orally active activator of adenosine monophosphate-activated protein kinase (AMPK), ASP4132, as a clinical candidate for the treatment of human cancer. Bioorg Med Chem. 2020 Mar 01;28(5):115307. doi: 10.1016/j.bmc.2020.115307. PMID: 32007387. |